Literature DB >> 11978832

Patterns of Nogo mRNA and protein expression in the developing and adult rat and after CNS lesions.

Andrea B Huber1, Oliver Weinmann, Christian Brösamle, Thomas Oertle, Martin E Schwab.   

Abstract

Nogo-A is a neurite growth inhibitor involved in regenerative failure and restriction of structural plasticity in the adult CNS. Three major protein products (Nogo-A, -B, and -C) are derived from the nogo gene. Here we describe the embryonic and postnatal expression of the three Nogo isoforms in the rat by in situ hybridization and immunohistochemistry. Northern and Western blot analysis indicated that Nogo-A is predominantly expressed in the nervous system with lower levels also present in testis and heart. In CNS myelin, confocal and immunoelectron microscopy revealed that Nogo-A is expressed in oligodendrocyte cell bodies and processes and localized in the innermost adaxonal and outermost myelin membranes. Additionally, we find Nogo-A to be expressed by projection neurons, in particular during development, and by postmitotic cells in the developing cortex, spinal cord, and cerebellum. The expression levels of Nogo-A/B were not changed significantly after traumatic lesions to the cortex or spinal cord. Nogo-B showed widespread expression in the central and peripheral nervous systems and other peripheral tissues. Nogo-C was mainly found in skeletal muscle, but brain and heart were also found to express this isoform. The localization of Nogo-A in oligodendrocytes fits well with its role as a myelin-associated inhibitor of regenerative fiber growth and structural plasticity. However, expression of Nogo-A in other tissues and, in particular, in neurons and the widespread expression of the two shorter isoforms, Nogo-B and -C, suggest that the Nogo family of proteins might have function(s) additional to the neurite growth-inhibitory activity.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11978832      PMCID: PMC6758364          DOI: 20026323

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  46 in total

1.  Reactions of oligodendrocytes to spinal cord injury: cell survival and myelin repair.

Authors:  E Frei; I Klusman; L Schnell; M E Schwab
Journal:  Exp Neurol       Date:  2000-06       Impact factor: 5.330

2.  NOGO mRNA expression in adult and fetal human and rat nervous tissue and in weight drop injury.

Authors:  A Josephson; J Widenfalk; H W Widmer; L Olson; C Spenger
Journal:  Exp Neurol       Date:  2001-06       Impact factor: 5.330

3.  Extension of long leading processes and neuronal migration in the mammalian brain directed by the chemoattractant netrin-1.

Authors:  K T Yee; H H Simon; M Tessier-Lavigne; D M O'Leary
Journal:  Neuron       Date:  1999-11       Impact factor: 17.173

Review 4.  Regeneration in the adult central nervous system: experimental repair strategies.

Authors:  L Olson
Journal:  Nat Med       Date:  1997-12       Impact factor: 53.440

Review 5.  Central nervous system regeneration: oligodendrocytes and myelin as non-permissive substrates for neurite growth.

Authors:  P Caroni; T Savio; M E Schwab
Journal:  Prog Brain Res       Date:  1988       Impact factor: 2.453

6.  Neurite growth inhibitors restrict plasticity and functional recovery following corticospinal tract lesions.

Authors:  M Thallmair; G A Metz; W J Z'Graggen; O Raineteau; G L Kartje; M E Schwab
Journal:  Nat Neurosci       Date:  1998-06       Impact factor: 24.884

7.  Nogo-A is a myelin-associated neurite outgrowth inhibitor and an antigen for monoclonal antibody IN-1.

Authors:  M S Chen; A B Huber; M E van der Haar; M Frank; L Schnell; A A Spillmann; F Christ; M E Schwab
Journal:  Nature       Date:  2000-01-27       Impact factor: 49.962

8.  Increased expression of the NG2 chondroitin-sulfate proteoglycan after brain injury.

Authors:  J M Levine
Journal:  J Neurosci       Date:  1994-08       Impact factor: 6.167

9.  A monoclonal antibody (IN-1) which neutralizes neurite growth inhibitory proteins in the rat CNS recognizes antigens localized in CNS myelin.

Authors:  B P Rubin; I Dusart; M E Schwab
Journal:  J Neurocytol       Date:  1994-04

10.  Application of neutralizing antibodies against NI-35/250 myelin-associated neurite growth inhibitory proteins to the adult rat cerebellum induces sprouting of uninjured purkinje cell axons.

Authors:  A Buffo; M Zagrebelsky; A B Huber; A Skerra; M E Schwab; P Strata; F Rossi
Journal:  J Neurosci       Date:  2000-03-15       Impact factor: 6.167

View more
  146 in total

1.  POSH is an intracellular signal transducer for the axon outgrowth inhibitor Nogo66.

Authors:  Heather M Dickson; Jonathan Zurawski; Huanqing Zhang; David L Turner; Anne B Vojtek
Journal:  J Neurosci       Date:  2010-10-06       Impact factor: 6.167

Review 2.  Strategies for identifying genes that play a role in spinal cord regeneration.

Authors:  M Wintzer; M Mladinic; D Lazarevic; C Casseler; A Cattaneo; J Nicholls
Journal:  J Anat       Date:  2004-01       Impact factor: 2.610

3.  Dendritic spine alterations in neocortical pyramidal neurons following postnatal neuronal Nogo-A knockdown.

Authors:  A D Pradhan; A M Case; R G Farrer; S Y Tsai; J L Cheatwood; J L Martin; G L Kartje
Journal:  Dev Neurosci       Date:  2010-10-13       Impact factor: 2.984

Review 4.  New Insights into the Roles of Nogo-A in CNS Biology and Diseases.

Authors:  Yun-Peng Sui; Xiao-Xi Zhang; Jun-Lin Lu; Feng Sui
Journal:  Neurochem Res       Date:  2015-08-13       Impact factor: 3.996

5.  Nogo-A knockdown inhibits hypoxia/reoxygenation-induced activation of mitochondrial-dependent apoptosis in cardiomyocytes.

Authors:  J P Sarkey; M Chu; M McShane; E Bovo; Y Ait Mou; A V Zima; P P de Tombe; G L Kartje; J L Martin
Journal:  J Mol Cell Cardiol       Date:  2011-03-17       Impact factor: 5.000

6.  Endothelial reticulon-4B (Nogo-B) regulates ICAM-1-mediated leukocyte transmigration and acute inflammation.

Authors:  Annarita Di Lorenzo; Thomas D Manes; Alberto Davalos; Paulette L Wright; William C Sessa
Journal:  Blood       Date:  2010-12-23       Impact factor: 22.113

7.  Intrathecal treatment with anti-Nogo-A antibody improves functional recovery in adult rats after stroke.

Authors:  Shih-Yen Tsai; Tiffanie M Markus; Ellen M Andrews; Joseph L Cheatwood; April J Emerick; Anis K Mir; Martin E Schwab; Gwendolyn L Kartje
Journal:  Exp Brain Res       Date:  2007-08-24       Impact factor: 1.972

8.  Nogo-A at CNS paranodes is a ligand of Caspr: possible regulation of K(+) channel localization.

Authors:  Du-Yu Nie; Zhi-Hong Zhou; Beng-Ti Ang; Felicia Y H Teng; Gang Xu; Tao Xiang; Chao-Yang Wang; Li Zeng; Yasuo Takeda; Tian-Le Xu; Yee-Kong Ng; Catherine Faivre-Sarrailh; Brian Popko; Eng-Ang Ling; Melitta Schachner; Kazutada Watanabe; Catherine J Pallen; Bor Luen Tang; Zhi-Cheng Xiao
Journal:  EMBO J       Date:  2003-11-03       Impact factor: 11.598

9.  Effect of combined treatment with methylprednisolone and soluble Nogo-66 receptor after rat spinal cord injury.

Authors:  Benxiu Ji; Mingwei Li; Stephane Budel; R Blake Pepinsky; Lee Walus; Thomas M Engber; Stephen M Strittmatter; Jane K Relton
Journal:  Eur J Neurosci       Date:  2005-08       Impact factor: 3.386

10.  Pericontusion axon sprouting is spatially and temporally consistent with a growth-permissive environment after traumatic brain injury.

Authors:  Neil G Harris; Yevgeniya A Mironova; David A Hovda; Richard L Sutton
Journal:  J Neuropathol Exp Neurol       Date:  2010-02       Impact factor: 3.685

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.